A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: inappropriate (103), not fitting (319), incompatible (7), improper (9)

Capecitabine-Cisplatin-Radiotherapy

Description
Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE-CISPLATIN (RADIOTHERAPY) Please note there is a capecitabine-cisplatin regimen th
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Radiotherapy.pdf

Laboratory medicine user handbook rev 22

Description
University Hospital Southampton NHS Foundation Trust LABORATORY MEDICINE G3.7 Laboratory Medicine user handbook rev 22 G3.7 Laboratory Medic
Url
/Media/UHS-website-2019/Docs/Services/Pathology/Lab-med/Laboratory-medicine-user-handbook.pdf

RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-Rituximab-Vincristine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-GEMCITABINE-PREDNISOLONE-RITUXIMAB-VINCRISTINE (RGCVP) Regimen Lymphoma–RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-RituximabVi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-Rituximab-Vincristine-Ver-1.2.pdf

VenetoclaxLow

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen • CLL –
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

VenetoclaxHigh

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) Indication • Venet
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

STH816 v1 Department of infection user handbook

Description
Microbiology and Specialist Virology Services User Handbook STH816/02-25 Issued Date 23.07.2025 Authorised by R. Allen Page 1 of 48 Contents About our Services Core Service hours On-
Url
/Media/UHS-website-2019/Docs/Services/Pathology/STH816-v1-Department-of-infection-user-handbook.pdf

Consent for a cannula

Description
Consent for a cannula
Url
/HealthProfessionals/Clinical-law-updates/Consent-for-a-cannula.aspx

Winspear

Description
In the summer of 2015, the views of the Department of Health (DH), the Nursing and Midwifery Council (NMC) and the
Url
/HealthProfessionals/Clinical-law-updates/Winspear.aspx

Your child has been referred for a hearing aid assessment - patient information

Description
This factsheet explains what to expect at your child's appointment and provides more information on hearing aids.
Url
/Media/UHS-website-2019/Patientinformation/Audiology/Your-child-has-been-referred-for-a-hearing-aid-assessment-2571-PIL.pdf

Gemcitabine (21day) ver1.1

Description
Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic urothelial cancer in patients unsuitable for cisplatin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf
1 to 10 of 30
Previous 1 2 3 Next